In head and neck squamous cell carcinoma (HNSC), esophageal carcinoma (ESCA), uterine corpus endometrial carcinoma (UCEC), colon adenocarcinoma (COAD), stomach adenocarcinoma (STAD), lung squamous cell carcinoma (LUSC), kidney renal clear cell carcinoma (KIRC), liver hepatocellular carcinoma (LIHC), and breast invasive carcinoma (BRCA), FADS2 mRNA level was elevated when compared to normal adjacent tissue (Fig. 1B). Here, FADS2 is linked to invasive breast carcinoma.